Dual STAT‑3 and IL‑6R inhibition with stattic and tocilizumab decreases migration, invasion and proliferation of prostate cancer cells by targeting the IL‑6/IL‑6R/STAT‑3 axisAníbal Samael Méndez-Clemente, Georgina Hernández‐Flores|Oncology Reports|2022Cited by 33
Pilot study on the efficacy and safety of berberine in people with metabolic syndrome and human immunodeficiency virus infectionVida Verónica Ruíz-Herrera, Luz Alicia González-Hernández, Jaime Andrade‐Villanueva et al.|International Journal of STD & AIDS|2023Cited by 9